Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Accelerating China, Covidien Establishes JV With Changzhou Kangdi

This article was originally published in PharmAsia News

Executive Summary

Irish device maker Covidien has set up a joint venture with Changzhou Kangdi to capture the value segment in China’s vast lower-tier market.

You may also be interested in...



Covidien Taps Local Players In China, Brazil To Reach Public Hospital Markets

Covidien acquired a privately held manufacturer of electrosurgical generators based in Ribeirao Preto, Brazil, and established a joint venture with a manufacturer of open stapler products based in Kiangsu Province in China, to access patients who can’t afford top-tier hospitals in those countries.

Brazilian Presidential Decree Opens Door To Less Stringent GMP Certification Requirements For Foreign Firms

New decree opens door to more lenient good manufacturing practice certification requirements than are currently imposed on international medical device manufacturers seeking to gain market entry in Brazil.

Journey East: How Chinese Returnees Build Global-Bound Biopharmas

As Chinese returnees transform their startups to fully-fledged biopharma operations with a full product lineup and the global market in sight, the journey has been filled with challenges. Based on interviews and on-the-ground reporting, this new series takes a closer look at several companies' experiences.

Topics

Related Companies

UsernamePublicRestriction

Register

OM016204

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel